SFGLC
PFE icon

Stonebridge Financial Group, LLC/CA’s Pfizer PFE Stock Holding History

Stonebridge Financial Group, LLC/CA’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$268K Buy
+11,147
New +$292K 0.04% 235

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Stonebridge Financial Group, LLC/CA's PFE Position: Q2 2026 in Review

Stonebridge Financial Group, LLC/CA opened a new position in Pfizer (PFE) in Q2 2026: 11,147 shares worth $268K. The stake represents 0.04% of the portfolio and ranks #235 among its holdings.

2,429 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Stonebridge Financial Group, LLC/CA held 11,147 shares of Pfizer worth $268K as of Q2 2026.
  • Pfizer was a new Stonebridge Financial Group, LLC/CA position in Q2 2026.
  • Pfizer made up 0.04% of Stonebridge Financial Group, LLC/CA's portfolio in Q2 2026, its #235 holding.
  • 2,429 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Stonebridge Financial Group, LLC/CA's 13F filing for Q2 2026, filed 13 Aug 2026.